Published in J Lipid Res on March 01, 2001
CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice. Biochem J (2005) 1.71
Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One (2009) 1.59
Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochem J (2002) 1.39
Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis. Nucleic Acids Res (2010) 1.34
A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver. Biochem J (2005) 1.22
Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse. Mol Syst Biol (2009) 1.18
The Role of PPARα Activation in Liver and Muscle. PPAR Res (2010) 1.07
Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor alpha (PPARalpha) activity. Proc Natl Acad Sci U S A (2011) 1.05
Nuclear receptors linking circadian rhythms and cardiometabolic control. Arterioscler Thromb Vasc Biol (2010) 1.04
Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem (2011) 1.02
Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism. Nucleic Acids Res (2008) 1.01
Pathogenesis of alcoholic liver disease: the role of nuclear receptors. Exp Biol Med (Maywood) (2010) 1.00
PPARs Integrate the Mammalian Clock and Energy Metabolism. PPAR Res (2014) 0.93
Gender disparity of hepatic lipid homoeostasis regulated by the circadian clock. J Biochem (2009) 0.91
Early nocturnal meal skipping alters the peripheral clock and increases lipogenesis in mice. Nutr Metab (Lond) (2012) 0.86
Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction. Front Physiol (2014) 0.85
Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. PLoS One (2014) 0.84
MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis. PLoS One (2015) 0.83
PPARs in Rhythmic Metabolic Regulation and Implications in Health and Disease. PPAR Res (2010) 0.82
Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle. BMC Genomics (2011) 0.81
Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice. Int J Mol Sci (2014) 0.79
Dietary proanthocyanidins modulate BMAL1 acetylation, Nampt expression and NAD levels in rat liver. Sci Rep (2015) 0.79
Role of PPARα in the control of torpor through FGF21-NPY pathway: From circadian clock to seasonal change in mammals. PPAR Res (2009) 0.78
PPARs and Mitochondrial Metabolism: From NAFLD to HCC. PPAR Res (2016) 0.77
A Moderate Zinc Deficiency Does Not Impair Gene Expression of PPARα, PPARγ, and Mitochondrial Enoyl-CoA Delta Isomerase in the Liver of Growing Rats. Nutr Metab Insights (2014) 0.77
Biological aging alters circadian mechanisms in murine adipose tissue depots. Age (Dordr) (2012) 0.77
Validation of the Antidiabetic and Hypolipidemic Effects of Hawthorn by Assessment of Gluconeogenesis and Lipogenesis Related Genes and AMP-Activated Protein Kinase Phosphorylation. Evid Based Complement Alternat Med (2013) 0.76
Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype. J Biol Chem (2014) 0.76
Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1. Cardiovasc Pathol (2015) 0.75
Distinct but complementary contributions of PPAR isotypes to energy homeostasis. J Clin Invest (2017) 0.75
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. Sci Rep (2017) 0.75
Fibroblast growth factor 21: a regulator of metabolic disease and health span. Am J Physiol Endocrinol Metab (2017) 0.75
Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia (2009) 2.03
Studies on the mechanism of the antifungal action of benzoate. Biochem J (1983) 1.97
The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas. Biochem J (1992) 1.91
Synthesis and function of hepatic very-low-density lipoprotein. Biochem Soc Trans (2004) 1.72
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia (2004) 1.65
The host protein required for in vitro replication of poliovirus is a protein kinase that phosphorylates eukaryotic initiation factor-2. Cell (1985) 1.64
Stability of plasma glucose during storage. Ann Clin Biochem (1990) 1.59
Ultrasound for the detection of foreign bodies. Ann Emerg Med (1991) 1.48
Degradation by cultured fibroblasts and macrophages of unmodified and 1,2-cyclohexanedione-modified low-density lipoprotein from normal and homozygous familial hypercholesterolaemic subjects. Biochem J (1982) 1.47
Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J (1988) 1.46
Concerning the role of lanosterol and cycloartenol in steroid biosynthesis. J Biol Chem (1971) 1.41
The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia (2005) 1.37
Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci (Lond) (1990) 1.31
Do attitude and area influence health? A multilevel approach to health inequalities. Health Place (2000) 1.29
Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism (1992) 1.26
Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol (1994) 1.24
Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia (2008) 1.23
Intracellular triacylglycerol lipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL). Adv Enzyme Regul (1995) 1.22
Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors. Proc Natl Acad Sci U S A (1989) 1.20
Long-term maintenance of high rates of very-low-density-lipoprotein secretion in hepatocyte cultures. A model for studying the direct effects of insulin and insulin deficiency in vitro. Biochem J (1989) 1.20
Effects of hormones and pyruvate on the rates of secretion of very-low-density lipoprotein triacylglycerol and cholesterol by rat hepatocytes. Biochim Biophys Acta (1985) 1.17
Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes. Biochem J (1988) 1.17
Regulation of cholesterol synthesis in the liver and mammary gland of the lactating rat. Biochem J (1983) 1.17
Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci (Lond) (1996) 1.13
Incorporation of (2-14C, (5r)-5-3H1) mevalonic acid into cholesterol by a rat liver homogenate and into beta-sitosterol and 28-isofucosterol by larix decidua leaves. Biochem J (1969) 1.12
National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol (2009) 1.12
Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul (1995) 1.12
Changes in the metabolism of modified and unmodified low-density lipoproteins during the maturation of cultured blood monocyte-macrophages from normal and homozygous familial hypercholesterolaemic subjects. Eur J Biochem (1982) 1.10
Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia. J Clin Invest (1999) 1.10
Metabolic characteristics of human adipose tissue in vivo. Clin Sci (Lond) (1989) 1.09
Is N-acetylglutamate a short-term regulator of urea synthesis? Biochem J (1984) 1.09
The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short- and long-term effects. Biochem J (1992) 1.09
Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. Hum Mol Genet (1996) 1.07
Changes in the sensitivity of lipogenesis in rat hepatocytes to hormones and precursors over the diurnal cycle and during longer-term starvation of donor animals. J Lipid Res (1984) 1.07
Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab (1998) 1.06
Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event. Arterioscler Thromb Vasc Biol (2001) 1.06
Storage, mobilization and secretion of cytosolic triacylglycerol in hepatocyte cultures. The role of insulin. Biochem J (1990) 1.05
Characterization of deletions in the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. Arterioscler Thromb (1992) 1.05
Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler Thromb (1994) 1.05
Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. Hum Mol Genet (1994) 1.05
The effect of noradrenaline on glyceride synthesis and oxidative metabolism in vitro in the brown fat of newborn rabbits. Biochem J (1971) 1.05
Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. Am J Physiol (1996) 1.05
A comparison between the effects of cold exposure in vivo and of noradrenaline in vitro on the metabolism of the brown fat of new-born rabbits. Biochem J (1970) 1.05
Detection of the low-density-lipoprotein receptor with biotin-low-density lipoprotein. A rapid new method for ligand blotting. Biochem J (1985) 1.04
The effect of cysteine oxidation on isolated hepatocytes. Biochem J (1983) 1.03
Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding. Arch Biochem Biophys (2001) 1.01
Effect of triarimol on cholesterol biosynthesis in rat-liver subcellular. Biochem Biophys Res Commun (1976) 1.01
Utilization of endogenous and exogenous sources of substrate for cholesterol biosynthesis by isolated hepatocytes. Biochem J (1979) 1.01
The relationship between the rate of hepatic sterol synthesis and the incorporation of [3H]water. J Lipid Res (1983) 0.99
Arteriovenous differences across human adipose and forearm tissues after overnight fast. Metabolism (1990) 0.99
A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms. Endocrinology (2005) 0.97
The regulation of 3-hydroxy-3-methylglutaryl-CoA reductase activity, cholesterol esterification and the expression of low-density lipoprotein receptors in cultured monocyte-derived macrophages. Biochem J (1983) 0.96
Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals. Biochem J (1989) 0.96
Hyperlipidaemia of diabetes. Clin Sci (Lond) (1986) 0.96
The metabolic route by which oleate is converted into cholesterol in rat hepatocytes. Biochem J (1986) 0.95
Diurnal variation in the activity of cholesterol 7 -hydroxylase in the livers of fed and fasted rats. FEBS Lett (1972) 0.95
Evidence that changes in hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity are required partly to maintain a constant rate of sterol synthesis. J Biol Chem (1984) 0.95
Acute effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br J Nutr (1998) 0.94
The effect of carbon monoxide on the nature of the accumulated 4,4-dimethyl sterol precursors of cholesterol during its biosynthesis from (2-14C)mevalonic acid in vitro. Biochem J (1973) 0.94
Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose. J Lipid Res (1999) 0.94
Plasma leptin is influenced by diet composition and exercise. Int J Obes Relat Metab Disord (2003) 0.94
Uptake of individual fatty acids into adipose tissue in relation to their presence in the diet. Am J Clin Nutr (2000) 0.93
Measurement of the absolute rates of cholesterol biosynthesis in isolated rat liver cells. Biochem J (1977) 0.93
Purification of a soluble template-dependent rhinovirus RNA polymerase and its dependence on a host cell protein for viral RNA synthesis. J Virol (1985) 0.93
Regulation of hepatic very-low-density lipoprotein secretion in rats fed on a diet high in unsaturated fat. Biochem J (1987) 0.93
Lanosterol 14alpha-demethylase. The metabolism of some potential intermediates by cell-free systems from rat liver. Biochem Biophys Res Commun (1976) 0.93
Immunoprecipitation of the low-density-lipoprotein (LDL) receptor and its precursor from human monocyte-derived macrophages. Biochem J (1986) 0.93
Structure and regulation of the LDL-receptor and its gene. Br Med Bull (1990) 0.92
Regulation of low-density-lipoprotein-receptor mRNA by insulin in human hepatoma Hep G2 cells. Eur J Biochem (1989) 0.92
Origin of hepatic very-low-density lipoprotein triacylglycerol: the contribution of cellular phospholipid. Biochem J (1996) 0.92
Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulation. J Biol Chem (2001) 0.92
Lipoprotein lipase transport in plasma: role of muscle and adipose tissues in regulation of plasma lipoprotein lipase concentrations. J Lipid Res (1998) 0.92
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia. Atherosclerosis (1993) 0.92
Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolemia. J Lipid Res (1992) 0.92
Regulation of lipid metabolism in adipose tissue during early starvation. Am J Physiol (1996) 0.91
Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol (1995) 0.91
Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma Hep G2 cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL. Eur J Biochem (1988) 0.91
The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene. Biochem J (2000) 0.91
Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group. Arterioscler Thromb Vasc Biol (1997) 0.91
Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry (1992) 0.90
Degradation by cultured monocyte-derived macrophages from normal and familial hypercholesterolaemic subjects of modified and unmodified low-density lipoproteins. Biochem J (1982) 0.89
An antibody to the low-density lipoprotein (LDL) receptor that partially inhibits the binding of LDL to cultured human fibroblasts. Eur J Biochem (1988) 0.89
C/T polymorphism in the 5' untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb Vasc Biol (1995) 0.89
Detection and quantitation of apolipoprotein(a) mRNA in human liver and its relationship with plasma lipoprotein(a) concentration. Atherosclerosis (1991) 0.89
Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest (1994) 0.89
The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly. J R Soc Med (2002) 0.89
Release of individual fatty acids from human adipose tissue in vivo after an overnight fast. J Lipid Res (1996) 0.88
Peripheral fat metabolism during infusion of an exogenous triacylglycerol emulsion. Int J Obes Relat Metab Disord (1998) 0.88
Effects of insulin on human adipose tissue metabolism in vivo. Clin Sci (Lond) (1989) 0.88